Detailed Mechanism Funding and Narrative

Years of mechanism: 2016 2017 2018

Details for Mechanism ID: 18228
Country/Region: Cameroon
Year: 2017
Main Partner: Cameroon Baptist Convention Health Services
Main Partner Program: NA
Organizational Type: FBO
Funding Agency: HHS/CDC
Total Funding: $2,141,989 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Testing: HIV Testing and Counseling (HVCT) $193,087
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $413,886
Treatment: Adult Treatment (HTXS) $1,364,671
Treatment: Pediatric Treatment (PDTX) $170,345
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 390,438
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2018 60,492
HTS_TST Service Delivery Point Agg Age (Facility) ANC: 15+, Negative 2018 68,664
HTS_TST Service Delivery Point Agg Age (Facility) Inpatient: <15, Female, Negative 2018 13,151
HTS_TST Service Delivery Point Agg Age (Facility) Inpatient: <15, Male, Negative 2018 12,480
HTS_TST Service Delivery Point Agg Age (Facility) Inpatient: 15+, Female, Negative 2018 21,170
HTS_TST Service Delivery Point Agg Age (Facility) Inpatient: 15+, Male, Negative 2018 20,637
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: <15, Female, Negative 2018 2,262
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: <15, Male, Negative 2018 4,283
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 84,892
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 83,411
HTS_TST Service Delivery Point Agg Age (Facility) TB: 15+, Female, Negative 2018 875
HTS_TST Service Delivery Point Agg Age (Facility) TB: 15+, Male, Negative 2018 784
HTS_TST Sum of Test Result disaggregates 2018 17,335
HTS_TST_POS By Test Result: Positive 2018 17,335
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2018 945
HTS_TST_POS Service Delivery Point Agg Age (Facility) ANC: 15+, Positive 2018 2,307
HTS_TST_POS Service Delivery Point Agg Age (Facility) Inpatient: <15, Female, Positive 2018 199
HTS_TST_POS Service Delivery Point Agg Age (Facility) Inpatient: <15, Male, Positive 2018 197
HTS_TST_POS Service Delivery Point Agg Age (Facility) Inpatient: 15+, Female, Positive 2018 1,422
HTS_TST_POS Service Delivery Point Agg Age (Facility) Inpatient: 15+, Male, Positive 2018 1,422
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: <15, Female, Positive 2018 42
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: <15, Male, Positive 2018 93
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 4,942
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 5,065
HTS_TST_POS Service Delivery Point Agg Age (Facility) TB: 15+, Female, Positive 2018 363
HTS_TST_POS Service Delivery Point Agg Age (Facility) TB: 15+, Male, Positive 2018 340
PMTCT_ART Already on ART at beginning of current pregnancy 2018 2,365
PMTCT_ART New on ART 2018 1,890
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 4,255
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 73,149
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 4,256
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 4,249
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 7
PMTCT_STAT By Age (Numerator): Unknown Age 2018 73,149
PMTCT_STAT By known positives: <Unknown Age 2018 2,516
PMTCT_STAT By new negatives: Unknown Age 2018 68,661
PMTCT_STAT By new positives: Unknown Age 2018 1,971
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 73,149
PMTCT_STAT_den By Age (Denominator): Unknown Age 2018 76,996
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 23
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 479
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 14
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 346
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 1,752
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 862
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 51
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 864
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 43
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 794
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 92
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 1,632
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 96
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 1,780
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 3,600
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 3,621
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 92
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 1,646
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 96
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 1,787
TX_CURR Aggregated Age/Sex: <15 Female 2018 3,968
TX_CURR Aggregated Age/Sex: <15 Male 2018 2,847
TX_CURR Aggregated Age/Sex: 15+ Female 2018 33,321
TX_CURR Aggregated Age/Sex: 15+ Male 2018 24,713
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 64,849
TX_CURR Sum of Aggregated Age/Sex <15 2018 6,815
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 58,034
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 64,849
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 680
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 651
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 10,379
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 7,645
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 19,355
TX_NEW Pregnancy status 2018 913
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 19,355
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 613
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 586
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 9,943
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 6,265
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 17,407
TX_RET Numerator by Status: Pregnant 2018 828
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 19,341
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 682
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 651
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 11,033
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 6,974
TX_RET_den Denominator by Status: Pregnant 2018 913
Cross Cutting Budget Categories and Known Amounts Total: $150,000
Motor Vehicles: Purchased $150,000